Heartseed (TSE:219A) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:219A Heartseed Inc TSE:219A
13 GF Score
Price 円1,886.00
! 1 Warning Sign
View Full Analysis

What is Heartseed Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSE:219A
13GF Score
Heartseed Inc TSE:219A
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Heartseed Business Description

Address 1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is a Japanese biotechnology company focused on developing and commercializing regenerative medicine treatments for severe heart failure. The company's product candidate, HS-001, involves transplanting clusters of purified heart muscle cells derived from iPSCs to the patient's heart to treat heart failure, especially Heart Failure with reduced Left Ventricular Ejection Fraction (HFrEF), including conditions such as Dilated Cardiomyopathy, Old Myocardial Infarction, and Dilated phase of Hypertrophic Cardiomyopathy.
13GF Score

Get the complete analysis for TSE:219A

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,886.00
Price